
Setipiprant
CAS No. 866460-33-5
Setipiprant ( ACT-129968 | ACT 129968 | KYTH 105 | Setipiprant )
产品货号. M19195 CAS No. 866460-33-5
Setipiprant 是一种口服的选择性 CRTH2 拮抗剂 (IC50: 6.0 nM)。 CRTH2 是前列腺素 (PGD2) 的 G 蛋白偶联受体。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥211 | 有现货 |
![]() ![]() |
10MG | ¥316 | 有现货 |
![]() ![]() |
25MG | ¥583 | 有现货 |
![]() ![]() |
50MG | ¥956 | 有现货 |
![]() ![]() |
100MG | ¥1531 | 有现货 |
![]() ![]() |
200MG | ¥2252 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Setipiprant
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Setipiprant 是一种口服的选择性 CRTH2 拮抗剂 (IC50: 6.0 nM)。 CRTH2 是前列腺素 (PGD2) 的 G 蛋白偶联受体。
-
产品描述Setipiprant is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in various inflammatory diseases, including allergy and asthma. Binding of PGD2 to CRTH2, which are expressed on the surface of blood-borne cells, induces chemotaxis of Th2 cells, basophils, and eosinophils, and stimulates cytokine release from these cells.(In Vitro):Setipiprant (0-10 μM; 90 min) interacts with hCRTH2 receptor in the absence and presence of Human Serum Albumin (HSA) in the assay buffer with IC50 values of 6 and 340 nM, respectively.Setipiprant (0-10 μM; 5-20 min) inhibits hCRTH2 receptor based intracellular calcium liberation, intracellular cAMP and shape change of human eosinophils with IC50 values of 30, 80 and 235 nM, respectively.Setipiprant (0-10 μM) inhibits prostanoid receptors hDP1, hEP2 and hEP4 with IC50 values of 1290, 2600 and >10000 nM, respectively.(In Vivo):Pharmacokinetic Properties of Setipiprant in Rats and Dogs.
-
体外实验Setipiprant (0-10 μM; 90 min) interacts with hCRTH2 receptor in the absence and presence ofHuman Serum Albumin (HSA) in the assay buffer with IC50 values of 6 and 340 nM, respectively.Setipiprant (0-10 μM; 5-20 min) inhibits hCRTH2 receptor based intracellular calcium liberation, intracellular cAMP and shape change of human eosinophils with IC50 values of 30, 80 and 235 nM, respectively.Setipiprant (0-10 μM) inhibits prostanoid receptors hDP1, hEP2 and hEP4 with IC50 values of 1290, 2600 and >10000 nM, respectively.
-
体内实验——
-
同义词ACT-129968 | ACT 129968 | KYTH 105 | Setipiprant
-
通路Others
-
靶点Other Targets
-
受体CRTh2
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number866460-33-5
-
分子量402.42
-
分子式C24H19FN2O3
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 36 mg/mL; 89.46 mM
-
SMILESC1CN(CC2=C1N(C3=C2C=C(C=C3)F)CC(=O)O)C(=O)C4=CC=CC5=CC=CC=C54
-
化学全称2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)acetic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Diamant Z., et al. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics. Clin Exp Allergy. 2014 Aug;44(8):1044-52.
产品手册




关联产品
-
L-Dihydroorotic acid
L-二氢乳清酸,也称为(S)-4,5-二氢乳清酸盐或二氢-L-乳清酸盐,属于称为α氨基酸及其衍生物的有机化合物类别。
-
Ipilimumab
Ipilimumab抗CTLA-4)是一种针对细胞表面抗原CTLA-4的免疫调节单克隆抗体,也是一种免疫检查点抑制剂。
-
Pseudo RACK1
Activator of protein kinase C; attached to cell permeabilization Antennapedia domain vector peptide. Consists of peptide derived from the C2 domain of PKC β linked by a disulfide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the activator peptide. Once inside the cell, the disulfide bonds are subjected to reduction in the cytoplasm leading to release of the activator peptide.